Sumitomo Life Insurance’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.56M | Buy |
152,429
+16,057
| +12% | +$1.28M | 0.22% | 48 |
|
|
2025
Q4 | $13M | Buy |
136,372
+8,771
| +7% | +$860K | 0.36% | 39 |
|
|
2025
Q3 | $12.5M | Buy |
127,601
+22,663
| +22% | +$2.35M | 0.39% | 41 |
|
|
2025
Q2 | $11.3M | Sell |
104,938
-6,543
| -6% | -$662K | 0.76% | 25 |
|
|
2025
Q1 | $11.2M | Buy |
111,481
+11,623
| +12% | +$1.17M | 0.4% | 30 |
|
|
2024
Q4 | $8.92M | Buy |
99,858
+10,098
| +11% | +$889K | 0.17% | 40 |
|
|
2024
Q3 | $7.52M | Sell |
89,760
-12,150
| -12% | -$958K | 0.15% | 40 |
|
|
2024
Q2 | $6.46M | Sell |
101,910
-9,358
| -8% | -$685K | 0.15% | 45 |
|
|
2024
Q1 | $6.84M | Buy |
111,268
+42,009
| +61% | +$2.7M | 0.18% | 41 |
|
|
2023
Q4 | $4M | Buy |
69,259
+47,080
| +212% | +$2.51M | 0.12% | 52 |
|
|
2023
Q3 | $1.17M | Sell |
22,179
-333
| -1% | -$17.5K | 0.03% | 155 |
|
|
2023
Q2 | $1.22M | Sell |
22,512
-2,086
| -8% | -$109K | 0.05% | 158 |
|
|
2023
Q1 | $1.23M | Sell |
24,598
-253
| -1% | -$11.9K | 0.1% | 155 |
|
|
2022
Q4 | $1.15M | Sell |
24,851
-409
| -2% | -$17.7K | 0.08% | 158 |
|
|
2022
Q3 | $978K | Sell |
25,260
-2,838
| -10% | -$114K | 0.04% | 179 |
|
|
2022
Q2 | $1.05M | Sell |
28,098
-16,187
| -37% | -$659K | 0.03% | 183 |
|
|
2022
Q1 | $1.96M | Sell |
44,285
-793
| -2% | -$34.4K | 0.05% | 121 |
|
|
2021
Q4 | $1.92M | Sell |
45,078
-1,211
| -3% | -$50.9K | 0.05% | 134 |
|
|
2021
Q3 | $2.01M | Sell |
46,289
-1,957
| -4% | -$86.6K | 0.05% | 119 |
|
|
2021
Q2 | $2.06M | Sell |
48,246
-7,508
| -13% | -$316K | 0.07% | 113 |
|
|
2021
Q1 | $2.15M | Sell |
55,754
-12,500
| -18% | -$473K | 0.09% | 118 |
|
|
2020
Q4 | $2.45M | Sell |
68,254
-10,611
| -13% | -$382K | 0.1% | 96 |
|
|
2020
Q3 | $3.01M | Sell |
78,865
-3,389
| -4% | -$131K | 0.14% | 75 |
|
|
2020
Q2 | $2.89M | Sell |
82,254
-5,602
| -6% | -$202K | 0.15% | 73 |
|
|
2020
Q1 | $2.87M | Buy |
87,856
+5,600
| +7% | +$219K | 0.2% | 68 |
|
|
2019
Q4 | $3.72M | Buy |
82,256
+4,113
| +5% | +$172K | 0.42% | 60 |
|
|
2019
Q3 | $3.18M | Sell |
78,143
-9,997
| -11% | -$424K | 0.41% | 63 |
|
|
2019
Q2 | $3.79M | Buy |
88,140
+3,135
| +4% | +$121K | 0.45% | 59 |
|
|
2019
Q1 | $3.26M | Sell |
85,005
-24,602
| -22% | -$940K | 0.44% | 64 |
|
|
2018
Q4 | $3.87M | Sell |
109,607
-6,258
| -5% | -$227K | 0.54% | 50 |
|
|
2018
Q3 | $4.46M | Sell |
115,865
-16,154
| -12% | -$564K | 0.54% | 49 |
|
|
2018
Q2 | $4.32M | Buy |
132,019
+10,740
| +9% | +$324K | 0.53% | 48 |
|
|
2018
Q1 | $3.31M | Sell |
121,279
-5,422
| -4% | -$147K | 0.44% | 67 |
|
|
2017
Q4 | $3.14M | Sell |
126,701
-4,781
| -4% | -$132K | 0.39% | 76 |
|
|
2017
Q3 | $3.83M | Sell |
131,482
-3,102
| -2% | -$85.7K | 0.49% | 57 |
|
|
2017
Q2 | $3.73M | Buy |
134,584
+15,031
| +13% | +$399K | 0.49% | 58 |
|
|
2017
Q1 | $2.97M | Sell |
119,553
-1,079
| -0.9% | -$26.2K | 0.42% | 69 |
|
|
2016
Q4 | $2.61M | Sell |
120,632
-1,540
| -1% | -$33.6K | 0.37% | 77 |
|
|
2016
Q3 | $2.91M | Buy |
122,172
+7,438
| +6% | +$177K | 0.43% | 58 |
|
|
2016
Q2 | $2.68M | Sell |
114,734
-29,181
| -20% | -$631K | 0.37% | 78 |
|
|
2016
Q1 | $2.71M | Buy |
143,915
+62,201
| +76% | +$1.09M | 0.35% | 88 |
|
|
2015
Q4 | $1.51M | Sell |
81,714
-1,926
| -2% | -$34.5K | 0.19% | 175 |
|
|
2015
Q3 | $1.37M | Sell |
83,640
-2,129
| -2% | -$36.4K | 0.18% | 192 |
|
|
2015
Q2 | $1.52M | Buy |
+85,769
| New | +$1.53M | 0.19% | 192 |
|
Other funds holding BSX
VCM
VPM
Sumitomo Life Insurance's BSX Position: Q1 2026 in Review
Sumitomo Life Insurance increased its Boston Scientific (BSX) stake by 12% in Q1 2026, buying an estimated $1.28M and bringing the position to 152,429 shares worth $9.56M. The position accounts for 0.22% of the portfolio, ranked #48.
Sumitomo Life Insurance first reported a position in BSX in Q2 2015 and has held it in 44 quarters since. The position peaked at $13M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Sumitomo Life Insurance held 152,429 shares of Boston Scientific worth $9.56M as of Q1 2026.
- Sumitomo Life Insurance bought 16,057 Boston Scientific shares in Q1 2026, an estimated $1.28M.
- Boston Scientific made up 0.22% of Sumitomo Life Insurance's portfolio in Q1 2026, its #48 holding.
- Sumitomo Life Insurance first reported a position in Boston Scientific in Q2 2015 and has held it in 44 quarters since.
- Sumitomo Life Insurance's Boston Scientific position peaked at $13M in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.